Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 8, 2024 -- Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.
Patricia J. Rodriguez, Ph.D., from Truveta Inc. in Bellevue, Washington, and colleagues compared on-treatment weight loss and rates of gastrointestinal adverse events among adults with overweight or obesity receiving tirzepatide or semaglutide labeled for type 2 diabetes. After propensity score matching, 18,386 adults were included in the study.
The researchers found that participants receiving tirzepatide were significantly more likely to achieve weight loss than those receiving semaglutide (≥5, ≥10, and ≥15 percent weight loss hazard ratios: 1.76, 2.54, and 3.24, respectively). For patients receiving tirzepatide, on-treatment changes in weight were larger at three, six, and 12 months (differences, −2.4, −4.3, and −6.9 percent, respectively). The groups had similar rates of gastrointestinal adverse events.
"Individuals with overweight or obesity treated with tirzepatide were significantly more likely to achieve clinically meaningful weight loss and larger reductions in body weight compared with those treated with semaglutide," the authors write. "Consistent treatment effect estimates were observed in subgroups with and without type 2 diabetes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-09 07:15
Read more
- Fasting at Night May Aid Glucose Metabolism in Night-Shift Workers
- Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
- NIH Trial of Rectal Microbicide for HIV Prevention Begins in the United States
- Sleep Apnea Increases Risk for Dementia in Older Adults Over Time
- Genetic Testing Rate Lower for Blacks With Inherited Retinal Diseases
- Colonoscopy Still Beats New Blood Tests at Spotting Colon Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions